Similar studies for GEO DataSets (Select 200021231) - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO DataSets

Items: 3

Select item 2000212311.

Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis

(Submitter supplied) Although corticosteroids remain a mainstay of therapy for UC, a meta-regression of cohort studies in acute severe ulcerative colitis (UC) showed that 29% of patients fail corticosteroid therapy and require escalation of medical management or colectomy. We aimed to determine whether genes expressed in whole blood early following initiation of intravenous corticosteroid treatment can be associated with response.

Organism:: Homo sapiens

Type:: Expression profiling by array

Dataset:: GDS4270
Platform:: GPL6244
40 Samples

Download data: CEL

Series

Accession:: GSE21231

ID:: 200021231

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 42702.

Intravenous corticosteroid therapy effect on children with severe ulcerative colitis: peripheral blood

Analysis of peripheral blood from pediatric patients with severe ulcerative colitis (UC) on day 3 of intravenous corticosteroid (IVCS) therapy. Individual response to IVCS is variable. Results provide insight into the molecular mechanisms underlying response to IVCS in pediatric UC.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 individual sets

Platform:: GPL6244
Series:: GSE21231
40 Samples

Download data: CEL

DataSet

Accession:: GDS4270

ID:: 4270

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Select item 2000186063.

Transcript abundance patterns in Kawasaki disease patients IVIG-resistance

(Submitter supplied) We compared the abundance of gene transcripts of whole blood RNA between IVIG-resistant and –responsive KD patients to identify biomarkers that might differentiate between these two groups and to generate new targets for therapies in IVIG-resistant KD patients.